{
  "ticker": "TTX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963026",
  "id": "02963026",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250627",
  "time": "1504",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250627/pdf/06l60hrgmq99yj.pdf",
  "summary": "### **Tetratherix Limited (ASX:TTX) IPO Listing Announcement Summary**  \n\n- **IPO Listing**: Successfully listed on ASX; transitioned to publicly traded company.  \n- **Capital Structure**:  \n  - Total post-IPO shares on issue: **50,331,637** (including conversions).  \n  - Escrow restrictions apply to **~30.2M shares**, with lock-ups staggered until 2025\u20132027.  \n- **Use of Proceeds**: Funds to accelerate product development, clinical expansion, and manufacturing scale-up.  \n\n**No material financial/operational metrics or pricing details provided.**  \n\n*(Note: No trading halt, capital raising specifics, or cash balance disclosed.)*",
  "usage": {
    "prompt_tokens": 1081,
    "completion_tokens": 150,
    "total_tokens": 1231,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-27T06:23:16.809995"
}